Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil

7Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: The value of sputum smear microscopy (SSM) after 2 months of treatment in the management of pulmonary tuberculosis is controversial. We analysed second month-SSM conversion as a predictor of treatment success in Brazil. Results: Overall successful outcome rate was 89.4%. The predictive value of second month-SSM conversion for successful outcomes was 85.2% 72,479/85,118), while the predictive value of non-conversion for unfavourable outcomes was 26.9% (2712/10,071). Unfavourable treatment outcomes were twice more likely among patients who did not convert (adjusted OR = 2.06; 1.97-2.16).

Cite

CITATION STYLE

APA

Do Socorro Nantua Evangelista, M., Maia, R., Toledo, J. P., De Abreu, R. G., Braga, J. U., Barreira, D., & Trajman, A. (2018). Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil. BMC Research Notes, 11(1). https://doi.org/10.1186/s13104-018-3522-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free